Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

NCT04510597 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

364

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Stage IV Renal Cell Cancer AJCC v8

Interventions

PROCEDURE: Cytoreductive Nephrectomy
DRUG: Active Comparator

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]